Anondita Medicare Ltd IPO Price Range is ₹137 - ₹145, with a minimum investment of ₹1,45,000 for 2000 shares per lot.
Subscription Rate
3.078x
as on 22 Aug 2025, 05:00PM IST
Minimum Investment
₹1,45,000
/ 2000 shares
IPO Status
Live
Price Band
₹137 - ₹145
Bidding Dates
Aug 22, 2025 - Aug 26, 2025
Issue Size
₹69.50 Cr
Lot Size
2000 shares
Min Investment
₹1,45,000
Listing Exchange
NSE
as on 22 Aug 2025, 05:00PM IST
IPO subscribed over
🚀 3.078x
This IPO has been subscribed by 5.801x in the retail category and 0.114x in the QIB category.
Total Subscription | 3.078x |
Retail Individual Investors | 5.801x |
Qualified Institutional Buyers | 0.114x |
Non Institutional Investors | 1.921x |
Production capabilities.
Experienced management team and a motivated and efficient work force.
Cordial relations with our consumers.
Quality assurance and control.
The Company had negative cash flows from its operating, investing and financing activities in the past and may continue to have negative cash flows in the future. Sustained negative cash flow could impact the company growth and business.
The company depends on its top 10 customers for a significant portion of the company revenues. The loss of a major customer or significant reduction in demand from any of its major customers may adversely affect the company business, financial condition, results of operations and prospects.
The Company derives a significant portion of its revenue from government contracts and tenders for the supply of condoms under various public health initiatives. Participation in these tenders is subject to stringent regulatory compliance, quality standards, and other eligibility criteria. Any failures to meet the requirements enlisted in these tenders may result in the Company being debarred or disqualified from participating in future government tenders, which could have a material adverse effect on the company business, financial condition, and results of operations.
The company had obtained secured loans amounting to Rs. 2715.37 lakhs and unsecured loans amounting to Rs. 23.73 lakhs on a consolidated basis until March 31st 2025. As such any fluctuation in interest rates or change in repayment plan may adversely affect the Companys business. Moreover, unsecured loans could be recalled by Its lenders at any time, which may be earlier than anticipated, affecting the company repayment schedule.
Majority of assets, including both movable and immovable, have not yet been transferred under the name of the company.
The company Subsidiary, Anondita Healthcare and Rubber Products (India) Limited, have incurred losses in the past and may continue to do so in the future. Its may be required to fund the operations of the company Subsidiary in the future and Its investments in the company Subsidiary may eventually be written off, which could subject it to additional liabilities and could have an adverse effect on the Companys reputation, profitability and financial condition.
There is outstanding litigation pending against the company which, if determined adversely, could affect its business, results of operations and financial condition.
The company is dependent on third parties for the distribution and marketing of its products. If the company do not maintain and increase the number of its arrangements for the marketing and distribution of the company products, its business, financial condition and results of operations could be adversely affected.
Its top three states contribute its major revenue for the Financial year ended 31st March 2025, March 31st 2024, March 31st 2023. Any loss of business from one or more of these states may adversely affect the company revenues and profitability.
The company Registered Office and Corporate Office are shared with its promoter group companies and the same are not owned by it. Any termination of the relevant lease agreement in connection with such properties or its failure to pay annual lease rental, the same could adversely affect the company operations. If the company is required to vacate the same or if the company is unable to renew its current leases, due to any reason whatsoever, it may adversely affect the company business operations.